REQUEST A DEMO
Total
USD $0.00
Search more companies

Au Galen Pharm (Serbia)

Main Activities: Department Stores
Full name: Au Galen Pharm Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Au Galen Pharm is an enterprise based in Serbia. Its main office is in Belgrade. The company operates in the Department Stores industry. It was first established on January 29, 2007. Au Galen Pharm currently employs 560 (2024) people. In 2024, the company reported a net sales revenue increase of 9.03%. Its’ total assets recorded a growth of 47.38%. In, 2024, the company’s net profit margin decreased by 0.19%.

Headquarters
Beogradska 8
Belgrade; Belgrade;

Contact Details: Purchase the Au Galen Pharm report to view the information.

Website: http://www.galenpharm.com

Basic Information
Total Employees:
Purchase the Au Galen Pharm report to view the information.
Registered Capital:
Purchase the Au Galen Pharm report to view the information.
Financial Auditors:
Purchase the Au Galen Pharm report to view the information.
Incorporation Date:
January 29, 2007
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Apotekarska Ustanova Elixa
33.33%
Company Performance
Financial values in the chart are available after Au Galen Pharm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
9.03%
Total Operating Revenue
8.95%
Operating Profit
265.45%
EBITDA
203.08%
Net Profit/Loss for the Period
-45.32%
Total Assets
47.38%
Total Equity
2.91%
Operating Profit Margin
1.02%
Net Profit Margin
-0.19%
Return on Equity (ROE)
-2.54%
Debt / Equity
224.27%
Quick Ratio
-0.03%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?